Fredrik Bäckström

Net worth: 33 957 $ as of 30/03/2024

59 year

Producer Manufacturing

Electronic Technology

Profile

Fredrik Bäckström worked as the Vice President-Product Supply at Arcam AB from 2013 to 2019.
He also held the position of Vice President-Manufacturing & Supply at Carmel Pharma AB from 2000 to 2011.
Currently, he is serving as the Chief Operating Officer at Bulten AB, a position he started in 2019 and will continue until 2023.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
BULTEN AB 0.02%	24/08/2023	4,940 ( 0.02% )	33 957 $	30/03/2024

Former positions of Fredrik Bäckström

Companies	Position	End
BULTEN AB	Chief Operating Officer	31/07/2023
ARCAM AB (PUBL)	Corporate Officer/Principal	30/11/2019
Carmel Pharma AB Carmel Pharma AB Electronic Equipment/InstrumentsElectronic Technology Carmel Pharma AB manufactures PhaSeal System, a clinically proven closed-system drug transfer device (CSTD) for the safe handling of hazardous drugs. The company expanded its safe handling initiatives to the U.S. market with the formation of Carmel Pharma, Inc., which operates a corporate office and distribution facility out of Columbus, OH. Carmel Pharma AB was founded in 1994 and is headquartered in Gothenburg, Sweden.	Corporate Officer/Principal	-

See the detail of Fredrik Bäckström's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Fredrik Bäckström's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
BULTEN AB	Producer Manufacturing

Private companies	2
Arcam AB Arcam AB Industrial MachineryProducer Manufacturing Arcam AB engages in the development and commercialization of technologies for metal-based, freedom-in-design manufacturing. It develops, manufactures, and sells equipment and methods for Additive Manufacturing in metal. The company was founded in 1997 and is headquartered in Molndal, Sweden.	Producer Manufacturing
Carmel Pharma AB Carmel Pharma AB Electronic Equipment/InstrumentsElectronic Technology Carmel Pharma AB manufactures PhaSeal System, a clinically proven closed-system drug transfer device (CSTD) for the safe handling of hazardous drugs. The company expanded its safe handling initiatives to the U.S. market with the formation of Carmel Pharma, Inc., which operates a corporate office and distribution facility out of Columbus, OH. Carmel Pharma AB was founded in 1994 and is headquartered in Gothenburg, Sweden.	Electronic Technology